We spoke with our Tech Associate, Ajay Rayasam, and our Life Science Associate, Margalit Haber, for their perspectives on how best to initially interact with VCs. While some of their insights were similar, as with all individuals in the venture capital space, they did have differing opinions.
In late 2020, OUP hosted a webinar on Angel and Accelerator Funding for University Startups. We reconnected with two of the panelists, Ashok Kamal, Executive Director of Tech Coast Angels, and Jun Axup, Chief Science Officer and Partner of IndieBio, to continue the conversation about angel and accelerator funding in addition to answering some follow-up…
Corporate VCs have played a crucial role in financing life sciences companies for decades, but have you ever wondered what, if anything, makes them different from institutional venture capital funds? Join us for this webinar as we talk to a panel of investors at industry-leading CVC funds to learn more about their strategies, investment criteria, and how they measure success.
In January of 2020, the U.S. Federal Government issued final rules fully implementing the new powers granted to the Committee on Foreign Investment in the United States (CFIUS). Effective February 13, 2020, the Committee started to exercise its expanded ability to review the national security implications of more foreign investments – in particular companies with ‘novel or advanced technology’ including biotechnology, artificial intelligence, robotics, quantum computing, and advanced materials. New mandatory filing rules are now in place, and the Committee’s new enforcement team – charged with finding unfiled cases within CFIUS’s jurisdiction – is now bringing in far more cases than ever before.
A common practice across universities that hold equity in a company that IPOs is to sell all of its shares as soon as the lock up expires. But do the best returns necessarily come from selling all your stock immediately? When is the right time to sell stock in a therapeutics company?
When a university licenses technology to a startup, a grant of equity is a likely consideration offered by the licensee. To receive the equity, the university will review and negotiate a Stock Purchase Agreement – a legal agreement made between the corporation (startup) and the university that governs the transfer and sale of the corporation’s stock to the university and often related financial terms, which can impact the university’s potential returns.
It’s Spring, which means it is once again time for OUP’s annual financing trends webinar. Which sectors have had the greatest amounts of investment and which are facing funding challenges? How do these trends apply to advancing academic technologies? What does the beginning of 2019 imply for the rest of the year and what lies over the horizon?
We’re almost halfway through 2018, which means it is once again time for OUP’s annual financing trends webinar. Which sectors have had the greatest investment and which are facing funding challenges? How do these trends apply to advancing academic technologies? What does the beginning of 2018 imply for the rest of the year and what lies over the horizon?